- Home
- ZURA vs UHG Comparison
ZURA vs UHG Comparison
Compare ZURA & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | UHG |
|---|---|---|
| Founded | 2022 | N/A |
| Country | United States | United States |
| Employees | 30 | 175 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 68.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZURA | UHG |
|---|---|---|
| Price | $5.67 | $1.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.78 | N/A |
| AVG Volume (30 Days) | ★ 491.3K | 129.4K |
| Earning Date | 03-19-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.99 |
| 52 Week High | $7.25 | $4.78 |
Technical Indicators
Market Signals| Indicator | ZURA | UHG |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 34.29 |
| Support Level | $5.62 | $1.16 |
| Resistance Level | $5.75 | $1.81 |
| Average True Range (ATR) | 0.50 | 0.01 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 23.78 | 37.50 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.